SCHEMBL30890412

SCHEMBL30890412

CCCCOC(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1ccccc1NC2=O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ BCHE P06276 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ECE1 P42892 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890404 0.92 POLB (0.36) HSD17B10POLBTSHRBCHEMAPT
SCHEMBL30890444 0.92 POLB (0.36) HSD17B10POLBTSHRBCHEMAPT
SCHEMBL30890780 0.88 MAOB (0.34) TSHRMAPTMEN1KMT2AALDH1A1
SCHEMBL30890571 0.88 MAPT (0.34) MAPTMEN1KMT2AL3MBTL1
SCHEMBL30890510 0.86 OTUD7B (0.40) HSD17B10POLBTSHRBCHEMEN1
SCHEMBL30890474 0.86 TSHR (0.32) TSHRMEN1KMT2ARECQL
SCHEMBL30890741 0.85 RECQL (0.34) POLBTSHRMAPTTDP1CYP3A4
SCHEMBL30890384 0.83 L3MBTL1 (0.34) POLBTSHRL3MBTL1CYP2C19
SCHEMBL30890482 0.83 POLB (0.40) HSD17B10POLB
SCHEMBL30890722 0.79 MEN1 (0.33) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback